[1]
Ruzicka T,Assmann T,Lebwohl M, Potential future dermatological indications for tacrolimus ointment. European journal of dermatology : EJD. 2003 Jul-Aug; [PubMed PMID: 12948911]
[2]
Thomson AW,Bonham CA,Zeevi A, Mode of action of tacrolimus (FK506): molecular and cellular mechanisms. Therapeutic drug monitoring. 1995 Dec; [PubMed PMID: 8588225]
[3]
Vicari-Christensen M,Repper S,Basile S,Young D, Tacrolimus: review of pharmacokinetics, pharmacodynamics, and pharmacogenetics to facilitate practitioners' understanding and offer strategies for educating patients and promoting adherence. Progress in transplantation (Aliso Viejo, Calif.). 2009 Sep; [PubMed PMID: 19813492]
[4]
Gaïes E,Salouage I,Sahnoun R,Trabelsi S,Jebabli N,Lakhal M,Klouz A, [Interaction between azole antifugals drugs and tacrolimus in four kidney transplant patients]. Journal de mycologie medicale. 2011 Mar; [PubMed PMID: 24451503]
[5]
Staatz CE,Tett SE, Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clinical pharmacokinetics. 2004 [PubMed PMID: 15244495]
[6]
Yu M,Liu M,Zhang W,Ming Y, Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of Tacrolimus in Kidney Transplantation. Current drug metabolism. 2018 [PubMed PMID: 29380698]
[7]
Patel N,Cook A,Greenhalgh E,Rech MA,Rusinak J,Heinrich L, Overview of extended release tacrolimus in solid organ transplantation. World journal of transplantation. 2016 Mar 24; [PubMed PMID: 27011912]
[8]
Nicolai S,Bunyavanich S, Hypersensitivity reaction to intravenous but not oral tacrolimus. Transplantation. 2012 Nov 15; [PubMed PMID: 23128975]
[9]
Takamatsu Y,Ishizu M,Ichinose I,Ogata K,Onoue M,Kumagawa M,Suzumiya J,Tamura K, Intravenous cyclosporine and tacrolimus caused anaphylaxis but oral cyclosporine capsules were tolerated in an allogeneic bone marrow transplant recipient. Bone marrow transplantation. 2001 Aug; [PubMed PMID: 11571519]
[10]
Bekersky I,Dressler D,Mekki Q, Effect of time of meal consumption on bioavailability of a single oral 5 mg tacrolimus dose. Journal of clinical pharmacology. 2001 Mar; [PubMed PMID: 11269569]
[11]
Philosophe B,Leca N,West-Thielke PM,Horwedel T,Culkin-Gemmell C,Kistler K,Stevens DR, Evaluation of Flexible Tacrolimus Drug Concentration Monitoring Approach in Patients Receiving Extended-Release Once-Daily Tacrolimus Tablets. Journal of clinical pharmacology. 2018 Jul; [PubMed PMID: 29462506]
[12]
Doligalski CT,Liu EC,Sammons CM,Silverman A,Logan AT, Sublingual administration of tacrolimus: current trends and available evidence. Pharmacotherapy. 2014 Nov; [PubMed PMID: 25251980]
[13]
Romero I,Jiménez C,Gil F,Escuin F,Ramirez E,Fudio S,Borobia A,Carcas A, Sublingual administration of tacrolimus in a renal transplant patient. Journal of clinical pharmacy and therapeutics. 2008 Feb; [PubMed PMID: 18211623]
[14]
Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group. Lancet (London, England). 1994 Aug 13 [PubMed PMID: 7520105]
[15]
Pham PT,Pham PM,Pham SV,Pham PA,Pham PC, New onset diabetes after transplantation (NODAT): an overview. Diabetes, metabolic syndrome and obesity : targets and therapy. 2011 [PubMed PMID: 21760734]
[16]
Nankivell BJ,PʼNg CH,OʼConnell PJ,Chapman JR, Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras. Transplantation. 2016 Aug [PubMed PMID: 27306529]